{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:56:14Z","timestamp":1780062974465,"version":"3.54.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ama121008"],"award-info":[{"award-number":["JP24ama121008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24bm1123027"],"award-info":[{"award-number":["JP24bm1123027"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ama221339"],"award-info":[{"award-number":["JP24ama221339"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24am0521010"],"award-info":[{"award-number":["JP24am0521010"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ck0106730"],"award-info":[{"award-number":["JP24ck0106730"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K06995"],"award-info":[{"award-number":["22K06995"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11652"],"award-info":[{"award-number":["24K11652"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07224"],"award-info":[{"award-number":["22K07224"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K20789"],"award-info":[{"award-number":["21K20789"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K07168"],"award-info":[{"award-number":["21K07168"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K18268"],"award-info":[{"award-number":["24K18268"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbrep.2025.101960","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T22:31:10Z","timestamp":1740090670000},"page":"101960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Development of a novel anti-erythropoietin-producing hepatocellular receptor B6 monoclonal antibody Eb6Mab-3 for flow cytometry"],"prefix":"10.1016","volume":"41","author":[{"given":"Tomohiro","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruto","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Satofuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika K.","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-5132","authenticated-orcid":false,"given":"Hiroyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5385-8201","authenticated-orcid":false,"given":"Yukinari","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2025.101960_bib1","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/sj.jid.5701184","article-title":"The epidermal growth factor receptor system in skin repair and inflammation","volume":"128","author":"Pastore","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbrep.2025.101960_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2353\/ajpath.2008.070942","article-title":"Beyond wavy hairs: the epidermal growth factor receptor and its ligands in skin biology and pathology","volume":"173","author":"Schneider","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrep.2025.101960_bib3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/jcp.21635","article-title":"The epidermal growth factor receptor ligands at a glance","volume":"218","author":"Schneider","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbrep.2025.101960_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tem.2005.01.008","article-title":"The role of insulin receptor signaling in the brain","volume":"16","author":"Plum","year":"2005","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.bbrep.2025.101960_bib5","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008912","article-title":"Receptor tyrosine kinases: legacy of the first two decades","volume":"6","author":"Schlessinger","year":"2014","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.bbrep.2025.101960_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2003.08.004","article-title":"Tyrosine kinase receptors as attractive targets of cancer therapy","volume":"50","author":"Bennasroune","year":"2004","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbrep.2025.101960_bib7","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ctrv.2014.08.003","article-title":"Prognostic relevance of receptor tyrosine kinase expression in breast cancer: a meta-analysis","volume":"40","author":"Templeton","year":"2014","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.bbrep.2025.101960_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41568-023-00634-x","article-title":"Eph receptors and ephrins in cancer progression","volume":"24","author":"Pasquale","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrep.2025.101960_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4161\/cam.4.3.11586","article-title":"Eph-ephrin bidirectional signaling comes into the context of lymphocyte transendothelial migration","volume":"4","author":"Trinidad","year":"2010","journal-title":"Cell Adhes. Migrat."},{"key":"10.1016\/j.bbrep.2025.101960_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2008.03.011","article-title":"Eph-ephrin bidirectional signaling in physiology and disease","volume":"133","author":"Pasquale","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bbrep.2025.101960_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7150\/ijms.5.263","article-title":"Eph receptors and ephrin signaling pathways: a role in bone homeostasis","volume":"5","author":"Edwards","year":"2008","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbrep.2025.101960_bib12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.biocel.2008.07.019","article-title":"Eph\/ephrin signaling in epithelial development and homeostasis","volume":"41","author":"Miao","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbrep.2025.101960_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2217\/fon.09.146","article-title":"Ephrin expression and function in cancer","volume":"6","author":"McCarron","year":"2010","journal-title":"Future Oncol."},{"key":"10.1016\/j.bbrep.2025.101960_bib14","first-page":"777","article-title":"A new member of the Eph family of receptors that lacks protein tyrosine kinase activity","volume":"13","author":"Gurniak","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrep.2025.101960_bib15","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1042\/BST20130104","article-title":"Receptor tyrosine kinases with intracellular pseudokinase domains","volume":"41","author":"Mendrola","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbrep.2025.101960_bib16","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1038\/s41388-019-0931-2","article-title":"Eph receptor signalling: from catalytic to non-catalytic functions","volume":"38","author":"Liang","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrep.2025.101960_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0014-5793(99)01793-7","article-title":"Ephrin-B2 is a candidate ligand for the Eph receptor, EphB6","volume":"466","author":"Munthe","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrep.2025.101960_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s42003-024-06118-4","article-title":"Co-clustering of EphB6 and ephrinB1 in trans restrains cancer cell invasion","volume":"7","author":"Liang","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbrep.2025.101960_bib19","doi-asserted-by":"crossref","first-page":"31111","DOI":"10.18632\/oncotarget.9080","article-title":"EphB6 overexpression and Apc mutation together promote colorectal cancer","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrep.2025.101960_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15200-3","article-title":"The EphB6 receptor is overexpressed in pediatric T cell acute lymphoblastic leukemia and increases its sensitivity to doxorubicin treatment","volume":"7","author":"El Zawily","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.101960_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s40364-023-00531-3","article-title":"A functional role of Ephrin type-B receptor 6 (EPHB6) in T-cell acute lymphoblastic leukemia","volume":"11","author":"Colucci","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bbrep.2025.101960_bib22","first-page":"11428","article-title":"High expression of EphB6 protein in tongue squamous cell carcinoma is associated with a poor outcome","volume":"8","author":"Dong","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbrep.2025.101960_bib23","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/onc.2009.18","article-title":"EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells","volume":"28","author":"Fox","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrep.2025.101960_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1175183","article-title":"Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer","volume":"13","author":"Jia","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrep.2025.101960_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044591","article-title":"Mutations of the EPHB6 receptor tyrosine kinase induce a pro-metastatic phenotype in non-small cell lung cancer","volume":"7","author":"Bulk","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2025.101960_bib26","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1074\/jbc.M108011200","article-title":"The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1","volume":"277","author":"Freywald","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2025.101960_bib27","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/0008-5472.CAN-09-1710","article-title":"The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells","volume":"70","author":"Truitt","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2025.101960_bib28","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.cellsig.2014.08.031","article-title":"EphB6 promotes anoikis by modulating EphA2 signaling","volume":"26","author":"Akada","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrep.2025.101960_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12253-014-9879-2","article-title":"Clinical significance of EphB4 and EphB6 expression in human malignant and benign thyroid lesions","volume":"22","author":"Giaginis","year":"2016","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.bbrep.2025.101960_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep43702","article-title":"Loss of the EPH receptor B6 contributes to colorectal cancer metastasis","volume":"7","author":"Mateo-Lozano","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.101960_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/CBM-160256","article-title":"Reduced EphB6 protein in gastric carcinoma and associated lymph nodes suggests EphB6 as a gastric tumor and metastasis inhibitor","volume":"19","author":"Liu","year":"2017","journal-title":"Cancer Biomarkers"},{"key":"10.1016\/j.bbrep.2025.101960_bib32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/carcin\/bgad041","article-title":"EphB6 deficiency in intestinal neurons promotes tumor growth in colorectal cancer by neurotransmitter GABA signaling","volume":"44","author":"Yu","year":"2023","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrep.2025.101960_bib33","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1158\/1078-0432.CCR-09-2000","article-title":"The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer","volume":"16","author":"Yu","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrep.2025.101960_bib34","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1541-7786.MCR-13-0673","article-title":"Dynamic interactions between cancer cells and the embryonic microenvironment regulate cell invasion and reveal EphB6 as a metastasis suppressor","volume":"12","author":"Bailey","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbrep.2025.101960_bib35","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/jclinpath-2015-203160","article-title":"Expression of EphB6 in ovarian serous carcinoma is associated with grade, TNM stage and survival","volume":"69","author":"Gu","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbrep.2025.101960_bib36","first-page":"1491","article-title":"High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas","volume":"5","author":"Tang","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrep.2025.101960_bib37","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1172\/JCI21846","article-title":"EphB6-null mutation results in compromised T cell function","volume":"114","author":"Luo","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrep.2025.101960_bib38","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI0215883","article-title":"EphB6 crosslinking results in costimulation of T cells","volume":"110","author":"Luo","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrep.2025.101960_bib39","first-page":"1","article-title":"EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression","volume":"51","author":"Yoon","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrep.2025.101960_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s40425-019-0679-9","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of the afucosylated, humanized anti-EPHA2 antibody DS-8895a: a first-in-human phase I dose escalation and dose expansion study in patients with advanced solid tumors","volume":"7","author":"Shitara","year":"2019","journal-title":"J. Immunother Cancer"},{"key":"10.1016\/j.bbrep.2025.101960_bib41","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10637-022-01237-3","article-title":"A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers","volume":"40","author":"Gan","year":"2022","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.bbrep.2025.101960_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.leukres.2016.09.012","article-title":"KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: results from a phase 1 study","volume":"50","author":"Swords","year":"2016","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrep.2025.101960_bib43","series-title":"Western Blot, and Immunohistochemical Analyses","article-title":"An anti-human EphA2 monoclonal antibody Ea2Mab-7 shows high sensitivity for flow cytometry","author":"Satofuka","year":"2024"},{"key":"10.1016\/j.bbrep.2025.101960_bib44","author":"Tanaka"},{"key":"10.1016\/j.bbrep.2025.101960_bib45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/mab.2023.0015","article-title":"Development of an anti-EphB4 monoclonal antibody for multiple applications against breast cancers","volume":"42","author":"Nanamiya","year":"2023","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"10.1016\/j.bbrep.2025.101960_bib46","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.pep.2014.01.009","article-title":"PA tag: a versatile protein tagging system using a super high affinity antibody against a dodecapeptide derived from human podoplanin","volume":"95","author":"Fujii","year":"2014","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bbrep.2025.101960_bib47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10014-015-0222-8","article-title":"Evaluation of IDH1 status in diffusely infiltrating gliomas by immunohistochemistry using anti-mutant and wild type IDH1 antibodies","volume":"32","author":"Ikota","year":"2015","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.bbrep.2025.101960_bib48","article-title":"Establishment of a highly sensitive and specific anti-EphB2 monoclonal antibody","volume":"MI","author":"Ubukata","year":"2025"},{"key":"10.1016\/j.bbrep.2025.101960_bib49","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbrep.2025.101960_bib50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.tcb.2006.07.003","article-title":"Emerging roles of pseudokinases","volume":"16","author":"Boudeau","year":"2006","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbrep.2025.101960_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158211","article-title":"The EphB6 receptor: kinase-dead but very much alive","volume":"22","author":"Strozen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2025.101960_bib52","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1242\/jcs.02777","article-title":"EphB2 and ephrin-B1 expressed in the adult kidney regulate the cytoarchitecture of medullary tubule cells through Rho family GTPases","volume":"119","author":"Ogawa","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbrep.2025.101960_bib53","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1074\/jbc.M111.293365","article-title":"Receptor tyrosine kinase Ephb6 regulates vascular smooth muscle contractility and modulates blood pressure in concert with sex hormones","volume":"287","author":"Luo","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2025.101960_bib54","doi-asserted-by":"crossref","first-page":"10150","DOI":"10.1074\/jbc.M208179200","article-title":"The EphB6 receptor inhibits JNK activation in T lymphocytes and modulates T cell receptor-mediated responses","volume":"278","author":"Freywald","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2025.101960_bib55","doi-asserted-by":"crossref","first-page":"29355","DOI":"10.1074\/jbc.M500010200","article-title":"Biphasic functions of the kinase-defective Ephb6 receptor in cell adhesion and migration","volume":"280","author":"Matsuoka","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2025.101960_bib56","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1373\/clinchem.2003.026849","article-title":"Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers","volume":"50","author":"Hafner","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbrep.2025.101960_bib57","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.18632\/oncotarget.2655","article-title":"Regulation of ERBB3\/HER3 signaling in cancer","volume":"5","author":"Mujoo","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrep.2025.101960_bib58","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/bs.mie.2022.03.044","article-title":"Targeting the HER3 pseudokinase domain with small molecule inhibitors","volume":"667","author":"Colomba","year":"2022","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbrep.2025.101960_bib59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jsb.2019.05.013","article-title":"Resolving the conformational dynamics of ErbB growth factor receptor dimers","volume":"207","author":"Pawar","year":"2019","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.bbrep.2025.101960_bib60","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/nchembio.1658","article-title":"Pharmacological targeting of the pseudokinase Her3","volume":"10","author":"Xie","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbrep.2025.101960_bib61","first-page":"115","article-title":"Spotlight on patritumab deruxtecan (HER3-DXd) from HERTHENA Lung01. Is a median PFS of 5.5 Months enough in light of FLAURA-2 and MARIPOSA?","volume":"15","author":"Arter","year":"2024","journal-title":"Lung Cancer (Auckl)"},{"key":"10.1016\/j.bbrep.2025.101960_bib62","first-page":"175","article-title":"The kinase defective EPHB6 receptor tyrosine kinase activates MAP kinase signaling in lung adenocarcinoma","volume":"35","author":"Yu","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrep.2025.101960_bib63","doi-asserted-by":"crossref","first-page":"955","DOI":"10.4149\/neo_2021_210309N304","article-title":"Determining the effects of Ephrin Type B Receptor 6 and Type A Receptor 3 on facilitating colorectal epithelial cell malignant transformation","volume":"68","author":"Wang","year":"2021","journal-title":"Neoplasma"},{"key":"10.1016\/j.bbrep.2025.101960_bib64","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1038\/s41388-018-0228-x","article-title":"EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours","volume":"37","author":"Toosi","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrep.2025.101960_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112670","article-title":"Integration of cancer-related genetic landscape of Eph receptors and ephrins with proteomics identifies a crosstalk between EPHB6 and EGFR","volume":"42","author":"Hanover","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrep.2025.101960_bib66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13058-019-1127-y","article-title":"Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer","volume":"21","author":"Kennedy","year":"2019","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbrep.2025.101960_bib67","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/ncomms8679","article-title":"Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2","volume":"6","author":"Zhou","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrep.2025.101960_bib68","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1126\/science.adg5314","article-title":"Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly","volume":"382","author":"Shi","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.bbrep.2025.101960_bib69","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1248\/bpb.b17-00446","article-title":"Emerging and diverse functions of the EphA2 noncanonical pathway in cancer progression","volume":"40","author":"Zhou","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrep.2025.101960_bib70","first-page":"1553","article-title":"Loss of EphB6 expression in metastatic melanoma","volume":"23","author":"Hafner","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrep.2025.101960_bib71","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1101\/gad.1973910","article-title":"Eph\/ephrin molecules--a hub for signaling and endocytosis","volume":"24","author":"Pitulescu","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrep.2025.101960_bib72","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1089\/mab.2021.0023","article-title":"Development of a novel epitope mapping system: RIEDL insertion for epitope mapping method","volume":"40","author":"Asano","year":"2021","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"10.1016\/j.bbrep.2025.101960_bib73","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/mab.2023.0029","article-title":"Epitope mapping of an anti-mouse CD39 monoclonal antibody using PA scanning and RIEDL scanning","volume":"43","author":"Okada","year":"2024","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"10.1016\/j.bbrep.2025.101960_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010161","article-title":"A cancer-specific monoclonal antibody against podocalyxin exerted antitumor activities in pancreatic cancer xenografts","volume":"25","author":"Suzuki","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2025.101960_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221833","article-title":"A cancer-specific anti-podoplanin monoclonal antibody, PMab-117-mG(2a) exerts antitumor activities in human tumor xenograft models","volume":"13","author":"Tanaka","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbrep.2025.101960_bib76","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/cas.16008","article-title":"Antitumor activities against breast cancers by an afucosylated anti-HER2 monoclonal antibody H(2) Mab-77-mG(2a) -f","volume":"115","author":"Tanaka","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrep.2025.101960_bib77","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.str.2024.02.007","article-title":"Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies","volume":"32","author":"Arimori","year":"2024","journal-title":"Structure"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825000470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825000470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:07:42Z","timestamp":1773864462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825000470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":77,"alternative-id":["S2405580825000470"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.101960","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a novel anti-erythropoietin-producing hepatocellular receptor B6 monoclonal antibody Eb6Mab-3 for flow cytometry","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.101960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101960"}}